RMFCX | TQCCX | RMFCX / TQCCX | |
Total Expense Ratio | 0.91 | 1.69 | 54% |
Annual Report Gross Expense Ratio | 0.91 | 1.78 | 51% |
Fund Existence | 23 years | 27 years | - |
Gain YTD | 4.725 | 2.958 | 160% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 105B | 2.29B | 4,579% |
Annual Yield % from dividends | 1.37 | 0.90 | 153% |
Returns for 1 year | 7.01 | 2.97 | 236% |
Returns for 3 years | 22.25 | 16.91 | 132% |
Returns for 5 years | 62.21 | 43.70 | 142% |
Returns for 10 years | 64.61 | 22.65 | 285% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
THOFX | 41.53 | 0.17 | +0.41% |
Thornburg Global Opportunities R5 | |||
FDETX | 25.26 | N/A | N/A |
Fidelity Advisor Capital Development O | |||
PHPSX | 18.40 | N/A | N/A |
ProFunds Pharmaceuticals UltraSector Svc | |||
UTMAX | 10.77 | N/A | N/A |
Victory Target Managed Allocation | |||
IGREX | 9.01 | -0.03 | -0.33% |
Invesco Global Real Estate R5 |